124 related articles for article (PubMed ID: 23818807)
1. Views of emergency physicians on thrombolysis for acute ischemic stroke.
Bobrow BJ; Demaerschalk BM; Wood JP; Villarin A; Clark L; Jennings A
J Brain Dis; 2009; 1():29-37. PubMed ID: 23818807
[TBL] [Abstract][Full Text] [Related]
2. Survey of emergency physicians about recombinant tissue plasminogen activator for acute ischemic stroke.
Brown DL; Barsan WG; Lisabeth LD; Gallery ME; Morgenstern LB
Ann Emerg Med; 2005 Jul; 46(1):56-60. PubMed ID: 15988427
[TBL] [Abstract][Full Text] [Related]
3. Views on the use of tissue plasminogen activator in acute ischemic stroke: a state-wide survey among neurologists and emergency medicine physicians in Indiana.
Meschia JF; Williams LS; Fleck JD; Bruno A; Biller J
J Stroke Cerebrovasc Dis; 1999; 8(4):207-10. PubMed ID: 17895166
[TBL] [Abstract][Full Text] [Related]
4. Safety and feasibility of intravenous rt-PA in the Emergency Department without a neurologist-based stroke unit: an observational study.
Tampieri A; Giovannini E; Rusconi AM; Cristoni L; Bendanti D; Cenni P; Lenzi T
Intern Emerg Med; 2015 Mar; 10(2):181-92. PubMed ID: 25430677
[TBL] [Abstract][Full Text] [Related]
5. Knowledge and Attitudes of Saudi Emergency Physicians toward t-PA Use in Stroke.
Al Khathaami AM; Aloraini H; Almudlej S; Al Issa H; Elshammaa N; Alsolamy S
Neurol Res Int; 2018; 2018():3050278. PubMed ID: 30364030
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Acute Ischemic Stroke Care and Outcomes Between Comprehensive Stroke Centers and Primary Stroke Centers in the United States.
Man S; Zhao X; Uchino K; Hussain MS; Smith EE; Bhatt DL; Xian Y; Schwamm LH; Shah S; Khan Y; Fonarow GC
Circ Cardiovasc Qual Outcomes; 2018 Jun; 11(6):e004512. PubMed ID: 29794035
[TBL] [Abstract][Full Text] [Related]
7. Sex Differences in rt-PA Utilization at Hospitals Treating Stroke: The National Inpatient Sample.
Boehme AK; Carr BG; Kasner SE; Albright KC; Kallan MJ; Elkind MSV; Branas CC; Mullen MT
Front Neurol; 2017; 8():500. PubMed ID: 29021776
[TBL] [Abstract][Full Text] [Related]
8. Development of a metropolitan matrix of primary stroke centers: the Phoenix experience.
Demaerschalk BM; Bobrow BJ; Paulsen M;
Stroke; 2008 Apr; 39(4):1246-53. PubMed ID: 18309157
[TBL] [Abstract][Full Text] [Related]
9. Emergency physician attitudes toward thrombolytic therapy in acute stroke.
Chaturvedi S; Bertasio B; Femino L
J Stroke Cerebrovasc Dis; 1998; 7(6):442-5. PubMed ID: 17895124
[TBL] [Abstract][Full Text] [Related]
10. Practice variation in the informed consent procedure for thrombolysis in acute ischemic stroke: a survey among neurologists and neurology residents.
Zonjee VJ; Slenders JPL; de Beer F; Visser MC; Ter Meulen BC; Van den Berg-Vos RM; van Schaik SM
BMC Med Ethics; 2021 Aug; 22(1):114. PubMed ID: 34433444
[TBL] [Abstract][Full Text] [Related]
11. Does time of day or physician experience affect outcome of acute ischemic stroke patients treated with thrombolysis? A study from Finland.
Helsinki Stroke Thrombolysis Registry Group
Int J Stroke; 2012 Aug; 7(6):511-6. PubMed ID: 22494345
[TBL] [Abstract][Full Text] [Related]
12. The "drip-and-ship" approach: starting IV t-PA for acute ischemic stroke at outside hospitals prior to transfer to a regional stroke center.
Silverman IE; Beland DK; Chhabra J; McCullough LD
Conn Med; 2005; 69(10):613-20. PubMed ID: 16381108
[TBL] [Abstract][Full Text] [Related]
13. Eligibility determination for intravenous thrombolysis based on radiology interpretation report of the head CT scan in patients with acute ischemic stroke.
Hassan AE; Majidi S; Janjua NA; Chaudhry SA; Tekle WG; Grigoryan M; Qureshi AI
J Neuroimaging; 2014; 24(4):349-53. PubMed ID: 24015702
[TBL] [Abstract][Full Text] [Related]
14. Joint commission primary stroke centers utilize more rt-PA in the nationwide inpatient sample.
Mullen MT; Kasner SE; Kallan MJ; Kleindorfer DO; Albright KC; Carr BG
J Am Heart Assoc; 2013 Mar; 2(2):e000071. PubMed ID: 23537806
[TBL] [Abstract][Full Text] [Related]
15. Emergency Medicine Physicians Accurately Select Acute Stroke Patients for Tissue-Type Plasminogen Activator Treatment Using a Checklist.
Berekashvili K; Zha AM; Abdel-Al M; Zhang X; Soomro JH; Prater SJ; Grotta JC
Stroke; 2020 Feb; 51(2):663-665. PubMed ID: 31771461
[TBL] [Abstract][Full Text] [Related]
16. Tissue plasminogen activator for acute ischemic stroke.
National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group
N Engl J Med; 1995 Dec; 333(24):1581-7. PubMed ID: 7477192
[TBL] [Abstract][Full Text] [Related]
17. Attitudes and beliefs of Michigan emergency physicians toward tissue plasminogen activator use in stroke: baseline survey results from the INcreasing Stroke Treatment through INteractive behavioral Change Tactic (INSTINCT) trial hospitals.
Scott PA; Xu Z; Meurer WJ; Frederiksen SM; Haan MN; Westfall MW; Kothari SU; Morgenstern LB; Kalbfleisch JD
Stroke; 2010 Sep; 41(9):2026-32. PubMed ID: 20705931
[TBL] [Abstract][Full Text] [Related]
18. Utilization of intravenous thrombolysis in 3-4.5 hours: analysis of the Minnesota stroke registry.
Tekle WG; Chaudhry SA; Hassan AE; Peacock JM; Lakshminarayan K; Tsai A; Luepker R; Anderson DC; Qureshi AI
Cerebrovasc Dis; 2012; 34(5-6):400-5. PubMed ID: 23221276
[TBL] [Abstract][Full Text] [Related]
19. [Effect of prehospital intervention based on emergency medical services on door-to-needle time of thrombolysis in acute ischemic stroke].
Wang Y; Zhang C; Sun W; Hu X; Lyu Z; Liu W
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Jul; 30(7):667-670. PubMed ID: 30045795
[TBL] [Abstract][Full Text] [Related]
20. Intravenous thrombolysis for acute ischemic stroke in the 3- to 4ยท5-hour window--the Malabar experience.
Salam KA; Ummer K; Pradeep Kumar VG; Noone ML
Int J Stroke; 2014 Jun; 9(4):426-8. PubMed ID: 23981667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
